My Multiple Myeloma has spread to my brain — what are my options

Multiple Myeloma with Brain Involvement: Understanding Your Options

I'm sorry you're facing this complication. Brain involvement in multiple myeloma is serious, but there are treatment approaches available. Let me help you understand what this means and what questions to ask your care team.

Understanding Brain Involvement in Myeloma

When myeloma spreads to the brain, it typically appears as leptomeningeal metastases (cancer cells in the fluid surrounding the brain and spinal cord) or brain metastases (tumors in the brain tissue itself). This is a significant development that requires specialized treatment planning.

According to NCCN Guidelines, brain involvement in myeloma is relatively uncommon but represents a serious complication that requires multidisciplinary evaluation—meaning your care team should include medical oncologists, radiation oncologists, and neurologists working together.

General Treatment Approaches for Brain Myeloma

STEP 1 - HOW DOCTORS THINK ABOUT THIS:

Oncologists typically evaluate brain myeloma involvement by considering:

• Location and extent of the disease (limited lesions vs. widespread involvement)
• Your overall health status and performance level
• Prior myeloma treatments you've received
• Whether systemic myeloma is controlled or progressing
• Symptoms you're experiencing (headaches, neurological deficits, etc.)

STEP 2 - GENERAL TREATMENT OPTIONS THAT EXIST:

For patients with brain myeloma involvement, doctors generally consider:

Systemic Therapy (Whole-Body Treatment)

• CNS-penetrating drugs: Some myeloma medications can cross the blood-brain barrier better than others
  • Certain proteasome inhibitors (like bortezomib/Velcade)
  • Immunomodulators (like lenalidomide/Revlimid)
  • Monoclonal antibodies (like daratumumab/Darzalex)
  • CAR T-cell therapy (increasingly used for resistant myeloma)
  • Bispecific antibodies (newer agents like teclistamab/Tecvayli)

According to NCCN Guidelines for Multiple Myeloma, when myeloma is found to be resistant to standard treatments, CAR T-cell therapy or bispecific antibodies become preferred options—and these may have activity in CNS disease.

Radiation Therapy

• Whole-brain radiation (WBRT) or hippocampal-avoidant WBRT (HA-WBRT) with memantine to protect memory
• Stereotactic radiosurgery (SRS) - focused radiation for limited lesions
• Combination approaches depending on disease extent

Per NCCN CNS Cancer Guidelines, radiation decisions depend on:

• Number and size of lesions
• Your performance status (ability to tolerate treatment)
• Whether you have other treatment options available

Supportive/Palliative Care

• Symptom management (pain, neurological symptoms)
• Best supportive care if aggressive treatment isn't appropriate

STEP 3 - CRITICAL QUESTIONS FOR YOUR CARE TEAM:

This is where YOUR specific situation matters. Ask your oncologist:

1. "Has my myeloma been tested for specific mutations or markers that might respond to targeted therapy or CAR T-cell therapy?" (This determines which drugs might work best for brain involvement)

2. "Which of my current or previous myeloma treatments have the best ability to cross the blood-brain barrier and reach brain lesions?"

3. "Is my systemic myeloma (throughout the body) currently controlled, or is it also progressing?" (This affects whether systemic therapy alone might work)

4. "Do you recommend radiation therapy, systemic therapy, or a combination approach for my specific brain involvement?"

5. "Should I be evaluated for CAR T-cell therapy or bispecific antibody treatment?" (These are increasingly used for resistant myeloma and may have CNS activity)

6. "What is the goal of treatment—to control the brain disease, manage symptoms, or both?"

7. "Are there clinical trials available for myeloma with CNS involvement?"

8. "What side effects should I expect, and how will we monitor whether treatment is working?"

Important Context

NCCN Guidelines emphasize that treatment for myeloma with brain involvement should be individualized based on:

• Your overall myeloma burden (how much disease you have throughout your body)
• Your health status and ability to tolerate intensive treatment
• Prior treatment responses
• Your goals and preferences

The American Cancer Society and NCCN both recommend seeking care at comprehensive cancer centers with experience treating myeloma, particularly when CNS involvement occurs.

What You Should Know

• Brain involvement in myeloma is serious but not automatically a death sentence—treatment options exist
• Multidisciplinary care is essential: You need coordination between your myeloma specialist, radiation oncologist, and neurologist
• Some newer myeloma drugs (CAR T-cell therapy, bispecific antibodies) may have better CNS penetration than older treatments
• Treatment decisions should balance controlling the cancer with maintaining quality of life and managing side effects

Next Steps

1. Request a multidisciplinary tumor board review of your case
2. Ask about genetic testing of your myeloma to identify targetable mutations
3. Discuss CAR T-cell therapy eligibility if you haven't already
4. Consider a second opinion from a myeloma specialist experienced with CNS complications
5. Ask about clinical trials specifically for myeloma with brain involvement

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your oncology team will determine the most appropriate approach for YOUR specific case based on your complete medical picture, imaging findings, and myeloma characteristics.